| Market Cap | ₹761Cr |
| ROE | 10.92% |
| P/E Ratio(TTM) | 19.82 |
| EPS(TTM) | 32.60 |
| P/B Ratio | 2.98 |
| Dividend Yield | 0.12% |
| Industry P/E | 31.89 |
| Book Value | 217.13 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
| Managing Director | Mr. Arpit Deepakkumar Shah |
| Founded | 2015 |
| NSE Symbol | REMUS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 77.99 | ||
| Anthem Biosciences | NA (0.00%) | 65.13 | ||
| Onesource Specialty Pharma | NA (0.00%) | 678.09 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 22.02 |